Will NVIDIA Be Knocked Off Its Perch By Quantum?
Earlier this month, NVIDIA CEO Jensen Huang seemingly dashed the hopes of speculative tech investors banking on quantum computing to become the next big thing in the ever-advancing race for faster and faster computer processing. Huang, speaking at the Consumer Electronics Show, stated his view that practical quantum computers were still about two decades away, causing a selloff among the stocks of quantum startups. » Read more about: Will NVIDIA Be Knocked Off Its Perch By Quantum? »
Read More
Alert: 43.7% Upside in POT Stock (No, Not That Pot)
Investment Alert: Buy Mosaic (MOS) Under $37/share
Disclaimer: Investment Alerts have a medium to long-term time horizon. These do not constitute financial advice and you should contact a financial advisor before deciding whether it is appropriate for your individual circumstances.
We found a pot stock with lots of upside,
» Read more about: Alert: 43.7% Upside in POT Stock (No, Not That Pot) »
Read More
Alert: 1 Stock That Is Too Damn Cheap To Ignore
Investment Alert: Buy DAVA Under $48/share
Disclaimer: Investment Alerts have a medium to long-term time horizon. These do not constitute financial advice and you should contact a financial advisor before deciding whether it is appropriate for your individual circumstances.
Jimmy McMillan sprung to fame a decade ago as the founder of the “Rent is Too Damn High”
» Read more about: Alert: 1 Stock That Is Too Damn Cheap To Ignore »
Read More
Market Commenary: Did Apple Silently Launch a Brain Machine Interface?
Ten years ago if you told someone that a brain-machine interface would connect humans to machines you would have been at risk of earning a tin foil hat and being labeled a conspiracy theorist.
Read More
Billionaire Buys Stake In Gene Therapy Stock
Ultragenyx may not have crossed your radar but it’s already in billionaire Stan Druckenmiller’s portfolio. What has he spotted in this novel therapies for rare and ultra-rare genetic diseases firm that convinced him to take a position?
Its focus on underserved patient populations, deep pipeline of innovative products, and strong track record in obtaining regulatory approvals make it an attractive long-term investment,
» Read more about: Billionaire Buys Stake In Gene Therapy Stock »
Read MoreThe Ivy
Pepsi’s Dividend Near All-time Highs
PepsiCo just kicked off 2025 on the wrong foot, posting disappointing first-quarter results and slashing its full-year guidance. The market didn’t take it lightly. Shares tumbled to a fresh 52-week low, and are now down over 19.8% over the 6 months, approaching levels not seen in nearly five years.
But here’s the twist,
» Read more about: Pepsi’s Dividend Near All-time Highs »
Read MoreThe Spotlight
Is Apple’s Dip The Perfect Buying Opportunity?
Apple has fallen by almost 15% from nearly $200 per share in recent months. The decline appeared to precede the major market averages more recent correction but does it bode ominously for Apple or has the recent pullback offered new buyers an opportunity to get in on a great company at sale prices?
In the near-term,
» Read more about: Is Apple’s Dip The Perfect Buying Opportunity? »
Read MoreThe Daily
Why is Warren Buffett sitting on $382 Billion of cash?
BERKSHIRE HATHAWAY CASH STASH AT 135% OF ITS PORTFOLIO
You often hear of fund managers holding cash and cash equivalents that is about 10% to 20% of their portfolios. But it is something really surprising when the cash stash of a fund is nearly 135% of the portfolio value.
» Read more about: Why is Warren Buffett sitting on $382 Billion of cash? »